These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 27502847

  • 1. Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
    Rao C, Du J, Li X, Li J, Zhang H, Zhao Y, Hu S, Jiang L, Zheng Z, MISSION-1 Collaborative Group.
    Am Heart J; 2016 Aug; 178():9-18. PubMed ID: 27502847
    [Abstract] [Full Text] [Related]

  • 2. Hospital revascularisation capability and quality of care after an acute coronary syndrome in Switzerland.
    Welker J, Auer R, Gencer B, Muller O, Cornuz J, Matter CM, Mach F, Windecker S, Rodondi N, Nanchen D.
    Swiss Med Wkly; 2016 Aug; 146():w14275. PubMed ID: 26859223
    [Abstract] [Full Text] [Related]

  • 3. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
    Makam RC, Erskine N, McManus DD, Lessard D, Gore JM, Yarzebski J, Goldberg RJ.
    Am J Cardiol; 2016 Dec 15; 118(12):1792-1797. PubMed ID: 27743577
    [Abstract] [Full Text] [Related]

  • 4. Secondary prevention of coronary artery disease in contemporary clinical practice.
    Jankowski P, Czarnecka D, Wolfshaut-Wolak R, Łysek R, Łukaszewska A, Bogacki P, Grodecki J, Mirek-Bryniarska E, Nessler J, Podolec P, Kawecka-Jaszcz K, Pająk A.
    Cardiol J; 2015 Dec 15; 22(2):219-26. PubMed ID: 25299500
    [Abstract] [Full Text] [Related]

  • 5. Effect of a smartphone-based intervention on secondary prevention medication prescriptions after coronary artery bypass graft surgery: The MISSION-1 randomized controlled trial.
    Qu J, Du J, Rao C, Chen S, Gu D, Li J, Zhang H, Zhao Y, Hu S, Zheng Z, MISSION-1 Collaborative Group.
    Am Heart J; 2021 Jul 15; 237():79-89. PubMed ID: 33689732
    [Abstract] [Full Text] [Related]

  • 6. Prescription Rates of Guideline-Directed Medications Are Associated With In-Hospital Mortality Among Japanese Patients With Acute Myocardial Infarction: A Report From JROAD - DPC Study.
    Nakao K, Yasuda S, Nishimura K, Noguchi T, Nakai M, Miyamoto Y, Sumita Y, Shishido T, Anzai T, Ito H, Tsutsui H, Saito Y, Komuro I, Ogawa H.
    J Am Heart Assoc; 2019 Apr 02; 8(7):e009692. PubMed ID: 30909774
    [Abstract] [Full Text] [Related]

  • 7. Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: A national effort to prompt quality enhancement for acute coronary syndrome.
    Hao Y, Liu J, Liu J, Smith SC, Huo Y, Fonarow GC, Ma C, Ge J, Taubert KA, Morgan L, Guo Y, Zhang Q, Wang W, Zhao D, CCC-ACS Investigators.
    Am Heart J; 2016 Sep 02; 179():107-15. PubMed ID: 27595685
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association of hospital myocardial infarction volume with adherence to American College of Cardiology/American Heart Association performance measures: Insights from the National Cardiovascular Data Registry.
    Harrison RW, Simon D, Miller AL, de Lemos JA, Peterson ED, Wang TY.
    Am Heart J; 2016 Aug 02; 178():95-101. PubMed ID: 27502856
    [Abstract] [Full Text] [Related]

  • 13. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
    El-Hajj MS, Saad A, Al-Suwaidi J, Al-Marridi WZ, Elkhalifa DH, Mohamed AA, Mahfoud ZR.
    Curr Vasc Pharmacol; 2016 Aug 02; 14(4):394-403. PubMed ID: 26916397
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.
    Barry AR, Koshman SL, Norris CM, Ross DB, Pearson GJ.
    Pharmacotherapy; 2014 May 02; 34(5):464-72. PubMed ID: 24877186
    [Abstract] [Full Text] [Related]

  • 15. Chronic polytherapy after myocardial infarction: the trade-off between hospital and community-based providers in determining adherence to medication.
    Di Martino M, Alagna M, Lallo A, Gilmore KJ, Francesconi P, Profili F, Scondotto S, Fantaci G, Trifirò G, Isgrò V, Davoli M, Fusco D.
    BMC Cardiovasc Disord; 2021 Apr 14; 21(1):180. PubMed ID: 33853534
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Impact of different intervention models on adherence to secondary prevention therapies in patients with acute coronary syndrome].
    Liu J, Wang W, Liu J, Wang Y, Qi Y, Sun JY, Zhao D.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Feb 24; 46(2):124-130. PubMed ID: 29495236
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India.
    Sharma KK, Gupta R, Agrawal A, Roy S, Kasliwal A, Bana A, Tongia RK, Deedwania PC.
    Vasc Health Risk Manag; 2009 Feb 24; 5():1007-14. PubMed ID: 19997570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.